Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03477526
Other study ID # Fibrosis 2016
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date February 26, 2019
Est. completion date February 27, 2019

Study information

Verified date November 2020
Source Schön Klinik Berchtesgadener Land
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

As the result of our last study "Long Term effects of an Inpatient Pulmonary Program in Patients with Pulmonary Fibrosis" already demonstrated the positive effects of a Pulmonary Rehabiliation on the mental status. In this current study the aim will be to analyse the personality type regarding anxiety and depression


Recruitment information / eligibility

Status Terminated
Enrollment 1
Est. completion date February 27, 2019
Est. primary completion date February 27, 2019
Accepts healthy volunteers No
Gender All
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria: - COPD GOLD III-IV - IPF according Pulmonary Guidelines Exclusion Criteria: < 30% FVC comorbidities with a negativ influence on the prognosis neurological and orthopaedic deficits, which make the participation of the pulmonary rehabilitation impossible non-compliance no written informed consent of the patient

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Pulmonary rehabilitation program
3 weeks, ...

Locations

Country Name City State
Germany Schön Klinik Berchtesgadener Land Schönau a.Königssee

Sponsors (2)

Lead Sponsor Collaborator
Schön Klinik Berchtesgadener Land Lungenfibrose e.V.

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anxiety score Hospital Anxiety and Depression scale 3 weeks
Secondary Anxiety score Hospital Anxiety and Depression scale 3 months